Cross Country Healthcare Yönetim

Yönetim kriter kontrolleri 2/4

Cross Country Healthcare CEO'su John Martins, Apr2022 tarihinde atandı, in görev süresi 2.58 yıldır. in toplam yıllık tazminatı $ 3.51M olup, şirket hissesi ve opsiyonları dahil olmak üzere 24.8% maaş ve 75.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.47% ine doğrudan sahiptir ve bu hisseler € 1.54M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.5 yıl ve 5.2 yıldır.

Anahtar bilgiler

John Martins

İcra Kurulu Başkanı

US$3.5m

Toplam tazminat

CEO maaş yüzdesi	24.8%
CEO görev süresi	2.6yrs
CEO sahipliği	0.5%
Yönetim ortalama görev süresi	3.5yrs
Yönetim Kurulu ortalama görev süresi	5.2yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

John Martins'un ücretlendirmesi Cross Country Healthcare'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	-US$2m
Jun 30 2024	n/a	n/a	US$8m
Mar 31 2024	n/a	n/a	US$46m
Dec 31 2023	US$4m	US$869k	US$73m
Sep 30 2023	n/a	n/a	US$102m
Jun 30 2023	n/a	n/a	US$124m
Mar 31 2023	n/a	n/a	US$156m
Dec 31 2022	US$3m	US$647k	US$188m
Sep 30 2022	n/a	n/a	US$227m
Jun 30 2022	n/a	n/a	US$216m
Mar 31 2022	n/a	n/a	US$175m
Dec 31 2021	US$1m	US$397k	US$132m

Tazminat ve Piyasa: John 'nin toplam tazminatı ($USD 3.51M ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.03M ).

Tazminat ve Kazançlar: John şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

John Martins (56 yo)

2.6yrs

Görev süresi

US$3,511,756

Tazminat

Mr. John A. Martins has been the President, Chief Executive Officer and a Director of Cross-Country Healthcare, Inc. since April 02022. He had been the Group President of Delivery at Cross Country Healthca...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kevin Clark	Co-Founder & Non-Executive Chairman of the Board	5.8yrs	US$310.00k	1.99% € 6.5m
John Martins	President	2.6yrs	US$3.51m	0.47% € 1.5m
William Burns	Executive VP & CFO	5.8yrs	US$1.50m	0.73% € 2.4m
Susan Ball	Chief Administrative Officer	20.5yrs	US$1.18m	0.53% € 1.7m
Marc Krug	Group President of Delivery	no data	US$953.25k	0.11% € 346.4k
James Redd	Senior VP & Chief Accounting Officer	2yrs	Veri yok	0.056% € 183.1k
Phillip Noe	Chief Information Officer	3.5yrs	Veri yok	0.031% € 100.9k
Joshua Vogel	Vice President of Investor Relations	2.7yrs	Veri yok	Veri yok
Karen Varga-Sinka	Director of Corporate Communications	no data	Veri yok	Veri yok
Gerald Purgay	Chief Marketing Officer	3.7yrs	Veri yok	Veri yok
Mark Fortunato	Vice President of Corporate Development	no data	Veri yok	Veri yok
Colin McDonald	Chief Human Resources Officer	no data	Veri yok	0.074% € 240.6k

3.5yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: XXY 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.5 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kevin Clark	Co-Founder & Non-Executive Chairman of the Board	5.8yrs	US$310.00k	1.99% € 6.5m
John Martins	President	2.6yrs	US$3.51m	0.47% € 1.5m
Mark Perlberg	Independent Director	9.5yrs	US$240.00k	0.28% € 926.2k
W. Cash	Lead Independent Director	23.1yrs	US$268.75k	0.59% € 1.9m
Gale Fitzgerald	Independent Director	17.5yrs	US$237.25k	0.53% € 1.7m
Janice Nevin	Independent Director	4.5yrs	US$225.00k	0.10% € 333.7k
Dwayne Allen	Independent Director	1.8yrs	US$287.50k	0.045% € 146.9k
Venkat Bhamidipati	Independent Director	2yrs	US$231.25k	0.045% € 146.5k

5.2yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: XXY 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.2 yıldır).

Cross Country Healthcare Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Insider recently sold €216k worth of stock

Chief Information Officer recently sold €126k worth of stock

Cross Country Healthcare, Inc., Annual General Meeting, May 14, 2024

Insider recently sold €97k worth of stock

Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024

Senior VP & Chief Accounting Officer recently sold €135k worth of stock

Recent updates

Third quarter 2024 earnings released: EPS: US$0.077 (vs US$0.37 in 3Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2024

Cross Country Healthcare, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Insider recently sold €216k worth of stock

Second quarter 2024 earnings released: US$0.47 loss per share (vs US$0.60 profit in 2Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2024

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 16%

Cross Country Healthcare, Inc. to Report Q2, 2024 Results on Jul 31, 2024

Chief Information Officer recently sold €126k worth of stock

First quarter 2024 earnings released: EPS: US$0.079 (vs US$0.82 in 1Q 2023)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2024

Cross Country Healthcare, Inc. Releases Latest Research Findings in the Fourth Annual Installment of the Future of Nursing Survey

Cross Country Healthcare, Inc. to Report Q1, 2024 Results on May 01, 2024

Cross Country Healthcare, Inc., Annual General Meeting, May 14, 2024

Insider recently sold €97k worth of stock

New minor risk - Share price stability

Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024

Full year 2023 earnings released: EPS: US$2.07 (vs US$5.09 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Now 23% undervalued after recent price drop

Cross Country Healthcare, Inc. to Report Q4, 2023 Results on Feb 21, 2024

Senior VP & Chief Accounting Officer recently sold €135k worth of stock

Investor sentiment deteriorates as stock falls 22%

Insider recently sold €122k worth of stock

Third quarter 2023 earnings released: EPS: US$0.37 (vs US$0.94 in 3Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023

Cross Country Healthcare, Inc. to Report Q3, 2023 Results on Nov 01, 2023

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: US$0.60 (vs US$1.41 in 2Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2023 and Updates Earnings Guidance for the Year 2023

Cross Country Healthcare, Inc. to Report Q2, 2023 Results on Aug 02, 2023

Cross Country Launches New Xperience App, Creating Comprehensive and Intuitive Job Searching Experience for Healthcare Professionals

First quarter 2023 earnings released: EPS: US$0.82 (vs US$1.67 in 1Q 2022)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2023

Full year 2022 earnings released: EPS: US$5.09 (vs US$3.60 in FY 2021)

Investor sentiment improves as stock rises 15%

Cross Country Healthcare, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Cross Country Healthcare, Inc. Appoints Eric Christianson as Its SVP, Intellify Solutions

Cross Country Healthcare, Inc. Appoints Dwayne L. Allen as Board of Directors

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) acquired Hireup Leadership Inc.

Investor sentiment deteriorated over the past week

Cross Country Healthcare, Inc. Announces Venkat Bhamidipati as Member of Board of Directors

Cross Country Healthcare, Inc. Promotes James V. Redd III to Senior Vice President and Chief Accounting Officer

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: US$0.94 (vs US$0.63 in 3Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

Cross Country Healthcare, Inc. to Report Q3, 2022 Results on Nov 02, 2022

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) acquired Substantially all of the assets of Mint Medical Physician Staffing, LP & Lotus Medical Staffing LLC from Mint Medical Physician Staffing, LP and Lotus Medical Staffing.

Cross Country Healthcare, Inc. Terminates Employment of Buffy S. White as Group President, Workforce solutions

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. Revising Financial Guidance for the Third Quarter of 2022

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) has entered into a definitive agreement to acquire Substantially all of the assets of Mint Medical Physician Staffing, LP & Lotus Medical Staffing LLC from Mint Medical Physician Staffing, LP and Lotus Medical Staffing.

Cross Country Healthcare Launches the New Crosscountry.Com

President recently bought €101k worth of stock

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. (NasdaqGS:CCRN) announces an Equity Buyback for $100 million worth of its shares.

Second quarter 2022 earnings released: EPS: US$1.41 (vs US$0.32 in 2Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Third Quarter of 2022

Cross Country Healthcare, Inc. Appoints Craig Hoven as Senior Vice President and Managing Consultant of Cejka Search

Investor sentiment improved over the past week

Cross Country Healthcare, Inc. to Report Q2, 2022 Results on Aug 03, 2022

Cross Country Healthcare, Inc.(NasdaqGS:CCRN) dropped from Russell 2000 Value-Defensive Index

First quarter 2022 earnings released: EPS: US$1.67 (vs US$0.54 in 1Q 2021)

Cross Country Healthcare, Inc. Provides Earnings Guidance for the Second Quarter of 2022

Cross Country Healthcare, Inc. to Report Q1, 2022 Results on May 04, 2022

Cross Country Healthcare Appoints Daniel J. White to New Chief Commercial Officer

Cross Country Healthcare, Inc., Annual General Meeting, May 17, 2022

Chief Administrative Officer recently sold €333k worth of stock